Inve US ▾
ODODC

Oil-Dri (ODC) Q4 FY26 earnings call: guidance and Q&A

Earnings call· Jul 2026 (Q4 FY26)· Materials· Oct 9, 2026

Source: earnings call transcript

Executive summary

Oil-Dri Q4 FY26 — Record annual results, all-time high Q4 sales and historic cash generation

A management-scripted, brief call with webcast-submitted Q&A. FY26 closed with a second-half catch-up after a deliberately flagged tough first half, with mix and new business doing the work while freight and depreciation squeeze margins. Balance sheet flexibility has been materially widened, and management signals bigger reinvestment and disciplined M&A as the next phase.

Highlights

5

  • Q4 business-to-business sales rose 4% to a record $50M; retail and wholesale rose 3% to $79M

  • Q4 operating income increased 17% YoY despite flat gross margin of 27.8%

  • Cash and cash equivalents reached a record $74M at fiscal year-end, up 45% from $51M; operating cash flow $80M and EBITDA $93M

  • Revolver raised 33% to $100M (accordion up 150% to $125M) and fixed-rate shelf raised 100% to $150M, lifting total borrowing capacity from $200M to $375M

  • Co-packaged cat litter grew 47% for the year and 60% in Q4; Amlan delivered an exceptional record Q4

Concerns

5

  • Gross margin held at 27.8% only through mix, price and cost actions; domestic gross COGS per ton rose 3% on freight/transportation costs (diesel, trucking capacity)

  • Retail and wholesale segment operating income fell 5% despite higher sales due to cat litter transport costs

  • Depreciation and amortization up 6% in the quarter, pressuring gross margins from ~4 years of steady investment

  • Fluids Purification sales declined 5% for the full year against a tough renewable diesel comparison

  • Branded cat litter faces rising slotting/customer investment costs outpacing pricing, retail consolidation and elevated competitor promotion; Amlan Q4 rate 'probably can't' be maintained

Guidance & targets

CategoryTargetConfidence
Capital expenditure level
Possibly higher than the ~$35M/yr of recent years; 'bigger reinvestment in the business at levels higher than you've seen in the past'
medium materiality
Low
Amlan sales growth
Very good year-over-year growth; Q4 rate unlikely to be maintained
low materiality
Medium
Acquisitions / capital allocation
Pursue disciplined, mission-led M&A in sorbent minerals using enhanced financing; prudent leverage
medium materiality
Low

Segment performance

SegmentRevenueYoYQoQMargin
Business-to-Business Products Group
Growth driven by animal health, agricultural products and mix; Amlan record Q4.
$50M (record, Q4)4%——
Retail and Wholesale Products Group
Higher cat litter transport costs drove the operating income decline despite higher sales.
Co-packaged cat litter sales growth: 60% in Q4 (47% full year)Branded cat litter national unit rank: #4
$79M (Q4)3%—Segment operating income down 5% YoY
Fluids Purification
Full-year decline against strong renewable diesel comparison; strongest quarter of the year in Q4.
—-5% (FY26)——

Product announcements

ProductTypeDetails
Amlan new poultry product (North America)launch
Cat's Pride antibacterialmilestone

Deals & partnerships

Two key financial partners (lenders, unnamed) Extension and upsizing of revolving credit facility and fixed-rate shelf facility Revolver $100M; accordion $125M; shelf $150M Extended (term not stated)

Relationships of decades.

Co-packaged lightweight cat litter customer(s) (undisclosed) Co-manufacturing of lightweight litter under longer-term agreements Not disclosed Longer-term

Confidentiality obligations limit disclosure; some capital invested to address bottlenecks.

Risks & headwinds

Freight, diesel and trucking capacity cost inflation Ongoing

Domestic gross COGS per ton +3% in Q4; retail and wholesale operating income -5%

Mitigation:Targeted price increases (some lagged), mix, cost reduction

Rising depreciation from sustained investment Continuing

D&A +6% in Q4; investing at this rate about four years

Mitigation:Monitor EBITDA; investments aimed at growth

Branded cat litter competition and retailer cost Ongoing

Slotting and customer investment rising faster than pricing; unquantified

Mitigation:Innovation, e-commerce, diversified branded/private label portfolio, disciplined promotion

Fluids Purification demand volatility Ongoing

Sales -5% in FY26

Mitigation:Retaining customer base

Amlan tariffs and Brazil account concentration FY27

Unquantified; Q4 rate unsustainable

Mitigation:New customers, distributors, regulatory tailwinds

What to watch in Q1 FY27

Gross margin vs freight pressure

Next quarter
Current 27.8% in Q4 FY26
Target Stable or higher as price increases lag in

Why it matters

Freight and D&A pressure test whether mix and pricing sustain margin

gross profit as a percent of sales or gross margin was under pressure and remained steady at 27.8%.

Find out whether ODC delivers this. Inve re-checks your case every morning.

Q&A highlights

Was Q4 seasonal and can the record be sustained?

Q4 was partly a rebound from Brazil key-account loss and tariffs; Asia, Brazil expansion, MAPA antibiotic bans, ruminant and new NA poultry products support growth, but the Q4 rate is not maintainable.

“That's a rate we probably can't maintain.”

asked by Ethan Starr / Robert Smith · answered by Unknown Speaker

2 min read 7 chapters

Detailed narrative

Quarter and year overview

Management framed FY26 as a year of weak first-half comparisons followed by a second-half recovery, delivering record full-year sales, net income and EBITDA and a record Q4. Q4 growth was broad-based across both product groups, led by improved product mix, animal health, agricultural products and co-packaged cat litter.

Margins and cost pressure

Gross margin was steady at 27.8% as freight, diesel and trucking capacity pressures lifted domestic gross COGS per ton 3%. D&A rose 6% from steady investment over about four years. Favorable mix, targeted price increases (some lagged with certain customers) and cost reductions offset these, and Q4 operating income rose 17%.

Cash generation and financing

Year-end cash was $74M versus $51M a year ago, with operating cash flow of $80M and EBITDA of $93M. Management emphasized EBITDA because non-cash depreciation from reinvestment weighs on gross margin. Two facilities were extended and enlarged, with favorable terms from long-standing lenders.

Capital allocation

Priorities are unchanged: reinvestment (FY26 capex $34M), dividend (raised twice, over $10M paid), strategic acquisitions in sorbent minerals, and opportunistic repurchases. The CFO signaled capex could rise above recent levels, and the M&A approach is described as disciplined and value-driven.

Amlan animal health

Q4 was exceptional, partly a rebound from the Brazil key-account loss and tariff effects earlier in the year. Growth drivers include Asia, Brazil co-ops and new distributors, MAPA registration changes and antibiotic bans (Apramycin, certain Bacitracin, Virginiamycin), ruminant/feedlot expansion, and new North American poultry products.

Fluids Purification and Ag

Fluids Purification fell 5% for the year against a strong renewable diesel comparison, with no customer losses and a strong Q4. Ag grew in every FY26 quarter on strong plantings (over 95 million acres of corn and about 85 million of soy) and partnerships with leading producers.

Cat litter dynamics

Co-packaged litter (lightweight) grew 47% for the year and 60% in Q4; management cited little interaction with its own brands and long-term agreements supporting capital put in, but disclosed no customer count or margin. Branded litter, the number four brand nationally in units, faces rising slotting and promotional costs, though promotional spending shows signs of subsiding from historic highs; e-commerce is growing.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.